Gene: MEIOC
Official Full Name: meiosis specific with coiled-coil domainprovided by HGNC
Gene Summary: Predicted to be involved in several processes, including germ cell development; germline cell cycle switching, mitotic to meiotic cell cycle; and meiosis I. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16257 | MEIOC Knockout cell line (HEK293) | Human | MEIOC | 1:3~1:6 | Negative | Online Inquiry |
KO16258 | MEIOC Knockout cell line (A549) | Human | MEIOC | 1:3~1:4 | Negative | Online Inquiry |
MEIOC Gene Knockout Cell Lines are genetically engineered cell lines that have had the MEIOC gene effectively inactivated through CRISPR-Cas9 technology. These cell lines offer researchers a powerful tool for elucidating the biological roles and pathways associated with the MEIOC gene, which is implicated in various cellular processes such as cell proliferation, differentiation, and response to external stimuli.
The primary function of these cell lines lies in their ability to facilitate targeted studies on the impact of MEIOC gene disruptions. By employing knockout models, researchers can investigate phenotypic changes, signaling pathways, and gene interactions that may occur as a result of MEIOC inactivation. Furthermore, MEIOC knockout cell lines serve as a valuable platform for drug testing and therapeutic development, enabling the identification of potential pharmacological targets.
From a scientific perspective, the applications of these knockout cell lines extend across diverse fields, including cancer research, regenerative medicine, and developmental biology. Understanding the functional consequences of MEIOC loss can lead to insights into various diseases and inform clinical practices related to diagnostics and treatment.
Compared to traditional methods of gene silencing, such as RNA interference, MEIOC Gene Knockout Cell Lines offer a more permanent and specific alteration of genetic content, leading to more reproducible results in experimental settings. The precision of CRISPR technology ensures off-target effects are minimized, enhancing data integrity—a distinct advantage for high-stakes research.
For researchers and clinicians seeking to enhance their understanding of gene function and associated disease mechanisms, MEIOC Gene Knockout Cell Lines represent an invaluable resource. This product is especially beneficial for those aiming to develop innovative strategies for disease intervention.
At [Your Company Name], we pride ourselves on our expertise in providing high-quality biotechnological products tailored for advanced research applications. Our commitment to scientific excellence and innovation allows us to support researchers in their quest for breakthroughs that will pave the way for future medical advancements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.